Brief: Nykode Therapeutics Q1 Net Loss Widens To USD 10.4 Mln
May 12 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* Q1 REVENUE USD 3.3 MILLION VERSUS USD 1.0 MILLION YEAR AGO
* Q1 NET LOSS USD 10.4 MILLION VERSUS LOSS USD 6.9 MILLION
YEAR
AGO
Source text for Eikon: ID:nObiGF11Ka
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026